Forty years of randomised trials in the New Zealand Medical Journal

New Zealand Medical Journal

Volumn 109, Issue 1031, 1996, Pages 372-373

  Neal, Bruce ^a,b   Rodgers, Anthony ^a   Mackie, Mary Jean ^a   MacMahon, Stephen ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MEDICAL SOCIETY; MEDLINE; METHODOLOGY; NEW ZEALAND; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS; STATISTICS;

DATA INTERPRETATION, STATISTICAL; HUMANS; MEDLINE; NEW ZEALAND; PERIODICALS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SOCIETIES, MEDICAL;

EID: 0030579993     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Dickersin K, Scherer R, Lefebvre C. Identification of relevant studies for systematic reviews. BMJ 1994; 309: 1286-91.
2. Fastier N. Effects of phenobarbitone, amphetamine and lactose on healthy subjects. NZ Med J 1955; 54: 74-9.
3. Mann S, on behalf of the ISIS group. Effect of streptokinase (SK) and aspirin (ASA) on mortality after acute myocardial infarction - the ISIS-2 trial. NZ Med J 1989; 102: 512-3.
4. ISIS-2 (second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither, among 17187 cases of acute myocardial infarction: ISIS-2. Lancet 1988; 2: 34-60.
5. Wach R, Darlow B, Bourchier D, Broadbent R, Knight D, Selby R. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf). NZ Med J 1994; 107: 234-7.
6. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials - the consort statement. JAMA 1996; 276: 637-9.